Serum profiling of uPA, PAI-1, and suPAR in systemic sclerosis: a preliminary study on analytical aspects and associations with microvascular and fibrotic manifestations

IntroductionIn systemic sclerosis (SSc), the laboratory panel lacks biomarkers able to predict the disease course and/or reflect the fibrotic activity in the skin and internal organs. We assessed the association of the serum levels of urokinase (urokinase plasminogen activator, uPA), plasminogen act...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Filomena Napolitano, Ilaria Mormile, Gabriele Mignogna, Amato de Paulis, Francesca Wanda Rossi, Nunzia Montuori
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Frontiers Media S.A. 2025-12-01
Edice:	Frontiers in Immunology
Témata:	urokinase plasminogen activator inhibitor-1 soluble urokinase plasminogen activator systemic sclerosis fibrosis microvascular abnormalities
On-line přístup:	https://www.frontiersin.org/articles/10.3389/fimmu.2025.1697785/full
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!